respiratory diseases

News

Redx shares soar after IPF drug licence deal with AstraZenec...

Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic disease drug RXC006 to AstraZeneca.

News

AZ's COPD triple therapy approved in the US

AstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), has been approved in the US following a re

News

Teva launches digital asthma and COPD rescue inhaler in US

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms.

Redx shares soar after IPF drug licence deal with AstraZenec...

AZ's COPD triple therapy approved in the US

Teva launches digital asthma and COPD rescue inhaler in US

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks